Physician profile

Ketan Patel

Pulmonary Disease · Tyler, TX

NPI 1174721310

$208,352.99

in general payments reported to CMS, 2019-2025

45 companies · $9,905 in 2025

The $9,905 reported for 2025 was more than what 93% of Pulmonary Disease providers received nationally (typical 2025 total: $500).

See the full distribution for Pulmonary Disease

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program$101,600.00
Food and Beverage$6,291.98
Travel and Lodging$5,348.64
Education$79.94

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Glaxosmithkline, LLC. $117,739.83 2019-2025 Arexvy, Trelegy Ellipta, Nucala
Astrazeneca Pharmaceuticals LP $74,168.81 2019-2025 Breztri, Airsupra, Fasenra
Sunovion Pharmaceuticals INC. $6,118.89 2019-2020
Intuitive Surgical, INC. $3,449.27 2019-2022
Ethicon INC. $1,028.06 2019
Mylan Specialty L.P. $871.63 2019-2024 Yupelri
Pulmonx Corporation $577.78 2019
Actelion Pharmaceuticals US, INC. $535.43 2019-2025 Opsumit
Harmony Biosciences LLC $512.67 2020-2025 Wakix
Auris Health, INC. $469.34 2019
Boehringer Ingelheim Pharmaceuticals, INC. $361.99 2019-2025 Ofev, Jascayd, Stiolto Respimat
Regeneron Healthcare Solutions, INC. $240.03 2023-2025 Dupixent
Inspire Medical Systems, INC. $225.86 2024-2025 Inspire
Genentech USA, INC. $187.87 2019-2023 Xolair, Actemra
Pfizer INC. $186.74 2023-2025
Show all 45 companies
CompanyGeneral paymentsYearsTop products
Gilead Sciences, INC. $169.01 2019-2023
Genzyme Corporation $158.90 2022-2025
Galvanize Therapeutics, INC $140.07 2025 Aliya System
Mallinckrodt Hospital Products INC. $119.44 2024 Acthar
Insmed, INC. $93.17 2023-2025 Arikayce, Brinsupri
Sanofi-Aventis U.S. LLC $90.09 2019-2020
Merck Sharp & Dohme LLC $81.21 2019-2025 Verquvo, Winrevair
Advanced Respiratory, INC $80.15 2019-2020
Grifols USA, LLC $77.81 2022-2025 Prolastin-C Liquid
Electromed, INC. $74.96 2022-2025 Smartvest
Takeda Pharmaceuticals U.S.A., INC. $58.17 2024-2025 Glassia, Cuvitru
Baxter Healthcare $54.71 2022-2024 Hillrom - Vest System Model 105 Home Care
Ani Pharmaceuticals, INC. $48.50 2022-2024 Purified Cortrophin Gel
Csl Behring $48.21 2019-2024 Privigen, Hizentra
Philips North America LLC $44.43 2019-2025 Home Pi Undivided
United Therapeutics Corporation $36.82 2019-2024 Tyvaso
Inogen, INC. $34.71 2023-2024 Inogen One G5 Oxygen Concentrator - Bluetooth
Jazz Pharmaceuticals INC. $34.06 2019
Abbvie INC. $32.45 2024-2025
Abiomed $31.06 2025
Shire North American Group INC $28.46 2019
Abbott Laboratories $20.20 2025 2nd Gen Centrimag Primary Console
3b Medical, INC. $18.73 2023 Luna
Hospira, INC. $16.86 2024
Resmed Corp $16.08 2023
Nabriva Therapeutics, Plc $15.70 2021
Fisher & Paykel Healthcare INC $15.44 2023 Fisher & Paykel Healthcare
Boston Scientific Corporation $13.84 2021
Axsome Therapeutics, INC. $13.79 2025 Sunosi
Janssen Biotech, INC. $11.76 2020

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Ketan Patel

$208,352.99

in general payments reported 2019-2025

Years
2019-2025
Top company
Glaxosmithkline, LLC.
Context
The $9,905 reported for 2025 was more than what 93% of Pulmonary Disease providers received nationally (typical 2025 total: $500).

https://glasscript.com/doctor/189522/ketan-patel

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.